SNM Global Biotech Portfolio Prepared as UN Launches Biotech Network for Developing Countries
13 Julho 2010 - 10:00AM
Marketwired
SNM Global Holdings (PINKSHEETS: SNMN) announced the launch of its
Biotech Initiatives to coincide with the recent launch by the
United Nations Industrial Development Organization (UNIDO) of the
International Industrial Biotechnology Network (IIBN).
Developing countries wanting to make more of their biotechnology
resources are the target of a network launched by the United
Nations.
George Tzotzos, IIBN programme coordinator, told SciDev.Net that
the network would provide biotechnology support and access to
high-level technologies for developing countries wanting to make
better use of their existing biological resources.
The IIBN will help local universities and small-to-medium
enterprises develop and improve existing biotechnology products. It
will also encourage further bio-prospecting. Ivan Ingelbrecht,
project manager for the IIBN and based at Ghent University,
Belgium, said the network would serve as a catalyst for
establishing North-South and South-South partnerships.
SNM Global's MicroTechnology Transfer (mt2) Program and
MicroEquity Partner Program enables the acquisition, development,
and transfer of technologies that will provide for the betterment
of society and provide the catalyst for emerging markets to
leapfrog into the sustainable sectors that will drive the
twenty-first century. The newly acquired technologies and/or
technology groups will be placed in the appropriate stage of the
Company's MicroTechnology Transfer (mt2) Program and MicroEquity
Partner Program.
In addition to its other vertical sectors, SNM Global Holdings
provides international emerging markets with alternative energy,
and decentralized power production technologies. The company also
provides biotech and healthcare related assets and technology to
these markets. The company believes its new and enhanced
operational plan will provide significant revenue, equity growth,
and serve the betterment of emerging economies.
SNM Global's MicroTechnology Transfer (mt2) Program is designed
to further the commercialization of promising technologies that
will benefit emerging markets in four key areas:
- Energy -- Clean, Renewable, and Sustainable Energy
- Health -- Better Health & Living
- Water -- Drinking Water, Irrigation & Sanitation
- Agriculture -- Green Biotechnology
The Company encourages collaboration with public, private and
institutional partners in all phases of the development and
technology transfer cycle; and accepts submissions from both
collaborative development, distribution and inventor partners
through the Collaboration Portal on its new website at
www.SNMNglobal.com
The company anticipates numerous technology and operational
acquisitions and will continue to provide regular updates. The
Company will soon announce additional details alongside full
operational and financial disclosures.
About SNM Global Holdings
SNM Global Holdings (SNM Global) is a technology holding and
development company that invests in, acquires, and develops
Intellectual Property Assets and Operations in the
Clean/Alternative Energy, Biotech, Water and Better Health &
Living sectors adapted specifically for the emerging global
markets.
The Company realizes revenues from the distribution of its
technology, products, and solutions through its network of
international agents and distributors and through the licensing of
Intellectual Property through its innovative mt2 Program. The
Company provides its International MicroEquity Partner program to
our local partners in our target international markets. This
program provides initial funding to a community building and
life-enhancing organization. The Company sees profits through
equity ownership and sales and distribution of its technology and
solutions.
The company operates through its subsidiaries and various
distribution partners worldwide. For more information, visit the
company's website at: www.snmnglobal.com
Safe Harbor
This release contains statements or projections regarding future
performance that is forward-looking statements as defined in the
Private Securities Litigation Reform Act of 1995. Actual results
may differ materially from those projected as a result of certain
risks and uncertainties. The company's filings contain various RISK
FACTORS (and are incorporated on the Company's website "Investors"
section by reference) and should be read before any investment
decision.
CONTACT: SNM Global Holdings St John's House London EC1V
4JL United Kingdom Tel Number: 020 7096 0200 Investor Relations:
1-(321)-251-6082 info@snmnglobal.com www.snmnglobal.com
SNM Global (CE) (USOTC:SNMN)
Gráfico Histórico do Ativo
De Ago 2024 até Set 2024
SNM Global (CE) (USOTC:SNMN)
Gráfico Histórico do Ativo
De Set 2023 até Set 2024